Equity Capital And Reserves Изменить Дата
Acorda Therapeutics USD 67.87M 9.09M 2023-06
Agios Pharmaceuticals USD 886.84M 77.39M 2023-09
ALKERMES USD 1.36B 75.15M 2023-09
Alnylam Pharmaceuticals USD -165866000 242.26M 2023-09
Amgen USD 7.66B 875M 2023-09
Biogen USD 14.48B 16.9M 2023-09
BioMarin Pharmaceutical USD 4.9B 114.07M 2023-09
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Gilead Sciences USD 22.31B 1.16B 2023-09
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 4.93B 190.76M 2023-09
Moderna USD 13.46B 3.49B 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
PTC Therapeutics USD -670810000 91.54M 2023-09
Regeneron Pharmaceuticals USD 24.9B 886.5M 2023-09
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
United Therapeutics USD 5.71B 301.1M 2023-09
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Gilead Sciences Собственный Капитал И Резервы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.